Riskpilot← Back to searchSign inGet full accessBIOSYM A/S
A/SActiveCVR 21774189Lene Haus Vej 25Wholesale of pharmaceutical and medical goods · NACE 4646Est. 199919 employees
Revenue 2024
DKK 16,2M
+6% vs 2023
EBITDA margin
36.3%
-3% vs 2023
Equity ratio
64.9%
Financial strength
Net profit 2024
DKK 3,8M
-7% vs 2023
| Revenue | DKK 16,2M | +6% |
| EBITDA | DKK 5,9M | -3% |
| Net profit | DKK 3,8M | -7% |
| Total assets | DKK 58,2M | +1% |
| Equity | DKK 37,8M | +11% |
| Employees | 19 | — |
Legal name
BIOSYM A/S
CVR number
21774189
Legal form
Aktieselskab
NACE code
4646 · Wholesale of pharmaceutical and medical goods
Founded
16. juni 1999
Share capital
DKK 900.000
Employees
19 (FTE)
VAT registered
Yes
Audit selected
Yes
Last report
2024-12-31
Financial year
January – December
Signatory rights
Selskabet tegnes af bestyrelsesformanden alene, af direktøren og et bestyrelsesmedlem i forening eller af den samlede bestyrelse.
Company purpose
Selskabets formål er salg af kosttilskud til førende helsekostbutikker og materialister i ind- og udland
Address
Lene Haus Vej 25
Phone
+4597252015
Email
info@biosym.dk
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | -7.130 | -4.665 | 6.125 | 7.639 | 13.963 | 11.640 | 14.766 | 28.135 | 17.951 | 18.635 | 12.991 | 15.335 | 16.196 |
| Staff expenses | -6.092 | -4.986 | -3.692 | -4.681 | -5.753 | -5.180 | -5.990 | -11.036 | -7.982 | -8.237 | -8.789 | -9.274 | -10.322 |
| EBITDA | -408 | 775 | 2.432 | 2.959 | 8.211 | 6.191 | 8.755 | 17.091 | 9.800 | 10.376 | 4.202 | 6.062 | 5.874 |
| Depreciation & amort. | -315 | -227 | -342 | -368 | -1.024 | -1.598 | -969 | -1.754 | -1.138 | -847 | -794 | -573 | -428 |
| EBIT | -723 | 548 | 2.090 | 2.590 | 7.187 | 4.593 | 7.786 | 15.337 | 8.662 | 9.530 | 3.408 | 5.489 | 5.446 |
| Net financials | -39 | -135 | -64 | 0 | -74 | -438 | -204 | -74 | -295 | -417 | -735 | -914 | -553 |
| Profit before tax | -731 | 682 | 2.027 | 2.591 | 7.113 | 4.155 | 7.582 | 15.264 | 8.367 | 9.113 | 2.673 | 4.575 | 4.893 |
| Tax | -195 | 128 | 495 | 594 | 1.508 | 1.311 | 1.621 | 3.485 | 1.689 | 2.005 | 563 | 463 | 1.082 |
| Net profit | -536 | 555 | 1.531 | 1.996 | 5.605 | 2.845 | 5.961 | 11.778 | 6.677 | 7.108 | 2.110 | 4.112 | 3.811 |
| Item | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | 13.335 | 12.565 | 15.034 | 19.570 | 23.720 | 19.460 | 27.875 | 42.136 | 50.015 | 55.319 | 71.573 | 57.826 | 58.197 |
| Equity | 6.580 | 6.025 | 7.557 | 9.553 | 15.157 | 12.502 | 14.463 | 13.963 | 20.641 | 27.749 | 29.859 | 33.970 | 37.781 |
| Long-term debt | 0 | 0 | 292 | 321 | 80 | 19 | 0 | 10.916 | 11.315 | 9.176 | 16.336 | 12.941 | 8.917 |
| Short-term debt | -6.749 | -6.539 | 6.288 | 8.432 | 8.400 | 6.939 | 13.389 | 17.257 | 18.059 | 18.394 | 25.378 | 10.915 | 11.500 |
| Total debt | -6.749 | -6.539 | 6.580 | 8.753 | 8.479 | 6.958 | 13.389 | 28.173 | 29.374 | 27.570 | 41.714 | 23.855 | 20.416 |
EBITDA margin
36.3%
This company
15.8%
Market median
+130% vs market
20122024
Equity ratio
64.9%
This company
38.2%
Market median
+70% vs market
20122024
Return on equity
10.1%
This company
18.4%
Market median
+45% vs market
20122024
Net profit margin
23.5%
This company
8.1%
Market median
+190% vs market
20122024
Asset turnover
0.28×
This company
1.12×
Market median
-75% vs market
20122024
Debt / equity
0.54×
This company
0.62×
Market median
+13% vs market
20122024
- Annual report 2024Filed via CVR / Virk · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via CVR / Virk · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via CVR / Virk · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via CVR / Virk · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via CVR / Virk · Period 2020-01-01 – 2020-12-31
- Annual report 2019Filed via CVR / Virk · Period 2018-07-01 – 2019-12-31
- Annual report 2018Filed via CVR / Virk · Period 2017-07-01 – 2018-06-30
- Annual report 2017Filed via CVR / Virk · Period 2016-07-01 – 2017-06-30
- Annual report 2016Filed via CVR / Virk · Period 2015-07-01 – 2016-06-30
- Annual report 2015Filed via CVR / Virk · Period 2014-07-01 – 2015-06-30
- Annual report 2014Filed via CVR / Virk · Period 2013-07-01 – 2014-06-30
- Annual report 2013Filed via CVR / Virk · Period 2012-07-01 – 2013-06-30
- Annual report 2012Filed via CVR / Virk · Period 2011-07-01 – 2012-06-30
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
KN Founder | Founder | 1999 | — | — |
SG Chief Executive Officer | Chief Executive Officer | 2012 | — | — |
SB Management | Management | 2020 | — | — |
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
| Board of Directors | 2019 | — | — | |
| Board of Directors | 1999 | — | — | |
| Board of Directors | 2008 | — | — | |
| Board of Directors | 2025 | — | — | |
| Board of Directors | 2019 | — | — | |
| Chairman | 2020 | — | — | |
| Board of Directors | 2020 | — | — | |
| Board of Directors | 1999 | — | — | |
| Chairman | 2024 | — | — |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Individual | 100.0% | 100.0% | 2019 | |
Bituin Finans ApS | Company | 100.0% | 100.0% | 2001 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of BIOSYM A/S also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Kim Nielsen | Founder | 0 companies |
| Susanne Genet | Chief Executive Officer | 0 companies |
| Sanne Biisgaard | Management | 0 companies |
| Ilona Odé-Haapiainen | Board of Directors | 0 companies |
| Bituin Guillermo Nielsen | Board of Directors | 0 companies |
| Michelle Castillo Kristensen | Board of Directors | 0 companies |
| Elina Liisa Maarit Haavisto | Board of Directors | 0 companies |
| Sebastian Nordman | Board of Directors | 0 companies |
| Sami Oinas | Chairman | 0 companies |
| Janne Vertanen | Board of Directors | 0 companies |
| Kurt Nielsen | Board of Directors | 0 companies |
| Kati Marika Rajala | Chairman | 0 companies |